DUODENAL-TYPE FOLLICULAR LYMPHOMA

Clinical trials for DUODENAL-TYPE FOLLICULAR LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new DUODENAL-TYPE FOLLICULAR LYMPHOMA trials appear

Sign up with your email to follow new studies for DUODENAL-TYPE FOLLICULAR LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New pill tested for Tough-to-Treat blood cancers

Disease control Recruiting now

This is a first-in-human study to test the safety of a new oral drug called SGR-1505 in adults with various types of relapsed or hard-to-treat B-cell cancers, like non-Hodgkin lymphoma and chronic lymphocytic leukemia. The main goal is to find the highest dose patients can tolera…

Matched conditions: DUODENAL-TYPE FOLLICULAR LYMPHOMA

Phase: PHASE1 • Sponsor: Schrödinger, Inc. • Aim: Disease control

Last updated Mar 23, 2026 15:17 UTC

DUODENAL-TYPE FOLLICULAR LYMPHOMA

Get alerted when new DUODENAL-TYPE FOLLICULAR LYMPHOMA trials appear

New pill tested for Tough-to-Treat blood cancers